Skip to main content

Research Repository

Advanced Search

Red-Emitting Dibenzodiazepinone Derivatives as Fluorescent Dualsteric Probes for the Muscarinic Acetylcholine M2 Receptor

She, Xueke; Pegoli, Andrea; Gruber, Corinna G.; Wifling, David; Carpenter, Jessica; H�bner, Harald; Chen, Mengya; Wan, Jianfei; Bernhardt, G�nther; Gmeiner, Peter; Holliday, Nicholas D.; Keller, Max

Red-Emitting Dibenzodiazepinone Derivatives as Fluorescent Dualsteric Probes for the Muscarinic Acetylcholine M2 Receptor Thumbnail


Authors

Xueke She

Andrea Pegoli

Corinna G. Gruber

David Wifling

Jessica Carpenter

Harald H�bner

Mengya Chen

Jianfei Wan

G�nther Bernhardt

Peter Gmeiner

Max Keller



Abstract

Fluorescently labeled dibenzodiazepinone-type muscarinic acetylcholine receptor (MR) antagonists, including dimeric ligands, were prepared using red-emitting cyanine dyes. Probes containing a fluorophore with negative charge showed high M2R affinities (pKi (radioligand competition binding): 9.10-9.59). Binding studies at M1 and M3-M5 receptors indicated a M2R preference. Flow cytometric and high-content imaging saturation and competition binding (M1R, M2R, and M4R) confirmed occupation of the orthosteric site. Confocal microscopy revealed that fluorescence was located mainly at the cell membrane (CHO-hM2R cells). Results from dissociation and saturation binding experiments (M2R) in the presence of allosteric M2R modulators (dissociation: W84, LY2119620, and alcuronium; saturation binding: W84) were consistent with a competitive mode of action between the fluorescent probes and the allosteric ligands. Taken together, these lines of evidence indicate that these ligands are useful fluorescent molecular tools to label the M2R in imaging and binding studies and suggest that they have a dualsteric mode of action.

Citation

She, X., Pegoli, A., Gruber, C. G., Wifling, D., Carpenter, J., Hübner, H., …Keller, M. (2020). Red-Emitting Dibenzodiazepinone Derivatives as Fluorescent Dualsteric Probes for the Muscarinic Acetylcholine M2 Receptor. Journal of Medicinal Chemistry, 63(8), 4133-4154. https://doi.org/10.1021/acs.jmedchem.9b02172

Journal Article Type Article
Acceptance Date Apr 1, 2020
Online Publication Date Apr 1, 2020
Publication Date Apr 23, 2020
Deposit Date Apr 13, 2020
Publicly Available Date Apr 2, 2021
Journal Journal of Medicinal Chemistry
Print ISSN 0022-2623
Electronic ISSN 1520-4804
Publisher American Chemical Society
Peer Reviewed Peer Reviewed
Volume 63
Issue 8
Pages 4133-4154
DOI https://doi.org/10.1021/acs.jmedchem.9b02172
Keywords Molecular Medicine; Drug Discovery
Public URL https://nottingham-repository.worktribe.com/output/4289616
Publisher URL https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02172
Additional Information This document is the Accepted Manuscript version of a Published Work that appeared in final form in Journal of Medicinal Chemistry ,copyright ©American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see
https://doi.org/10.1021/acs.jmedchem.9b02172